NVCR Q3 2025 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q3 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$167M+7.8% YoY

Gross Profit

$122M73.2% margin

Operating Income

-$36M-21.5% margin

Net Income

-$37M-22.3% margin

EPS (Diluted)

$-0.33

QoQ Revenue Growth

+5.3%

Cash Flow

Operating Cash Flow

$21M

Free Cash Flow

$15M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$1.0B

Stockholders' Equity

$341M

Cash & Equivalents

$345M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$167M	$155M	+7.8%
Gross Profit	$122M	$120M	+2.3%
Operating Income	-$36M	-$32M	-12.2%
Net Income	-$37M	-$31M	-21.9%

Geographic Segments

UNITED STATES

$97M45%

International Markets

$65M30%

GERMANY

$20M9%

FRANCE

$20M9%

JAPAN

$9M4%

CHINA

$6M3%